Vance’s Prescription Drug Monitoring Bill Passes Senate


HARRISBURG – The Senate today approved legislation authored by Sen. Pat Vance (R-Cumberland/York) that expands the state’s prescription drug monitoring program to include Schedule II through V controlled substances.

Currently, the Pennsylvania Attorney General oversees a monitoring program with dispensing data for Schedule II controlled substances. Under Senate Bill 1180, a board will be created within the Department of Health to establish and oversee an electronic data system listing all controlled substances that are prescribed and dispensed within Pennsylvania. An advisory group including dispensers, law enforcement, addiction specialists and privacy advocates will assist the board with its duties. Patients can annually review their information at no cost and correct any errors. Data will be referred to the appropriate licensing board only in instances when there is a pattern of irregular data deviating from the clinical standard.

“This legislation will empower physicians to make more educated decisions when writing prescriptions, thus prevent drug abuse,” Vance said. “In addition, by involving addiction specialists in the process, hopefully problems will be caught early and reduce the number of overdose deaths in the Commonwealth. Currently, Pennsylvania has the fourteenth highest drug overdose mortality rate nationwide.”

The bill now goes to the House of Representatives for its consideration.

Vance’s district includes all of Cumberland County and Carroll, Fairview, Franklin, Monaghan, Warrington and Washington townships and Dillsburg, Franklintown and Wellsville boroughs in York County.


Tracy Polovick
(717) 787-8524